ArticleAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2025
Cost-Effectiveness of Empagliflozin in Patients with Chronic Heart Failure Irrespective of Left-Ventricle Ejection Fraction in the Netherlands.
Bart P H Slob et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.